Skip to main content
. Author manuscript; available in PMC: 2014 May 16.
Published in final edited form as: Leuk Res. 2011 Sep 6;35(12):1585–1590. doi: 10.1016/j.leukres.2011.08.006

Table 3.

Multivariate analysis of IGFBP2 mRNA expression for response to induction therapy

Variable OR 95% CI P
Resistant disease
IGFBP2 high vs. low 3.6 1.2–11 0.02
sAML 3.1 1.1–8.8 0.04
CR
IGFBP2 high vs. low 0.3 0.09–0.8 0.01
sAML 0.3 0.09–0.7 0.01

OR: odds ratio, CI: confidence interval, CR: complete remission.

Variables considered for model inclusion are described in the statistical section. The final model is shown.